GRAND RAPIDS, Mich. (AP) -- The Grand Rapid-based Van Andel Institute and Michigan State University's medical school are helping test a drug that researchers say may ease the symptoms and halt the advance of Parkinson's disease.
Parkinson's is a degenerative brain disease that strikes when brain cells don't make enough of the chemical dopamine. That leads to symptoms including tremors, rigidity and slowness of movement.
The Michael J. Fox Foundation for Parkinson's Research is giving $400,000 for research on use of the drug Fasudil. Michigan State says the drug is approved in Japan to improve blood flow to the brain in stroke victims and has shown similar positive results in U.S. clinical trials.
According to Michigan State, Van Andel researchers recently found the potential of the drug in treating Parkinson's.